Login
$AMRZ
$40.23 +$0.99 (2.52%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Assets
Current Assets:
Cash and cash equivalents
Accounts receivable, net
Nonrelated Party
Related Party
Total accounts receivable, net
Inventories, net
Related-party notes receivable
Prepaid expenses and other current assets
Total current assets
Property, plant and equipment, net
Goodwill
Intangible assets, net
Operating lease right-of-use assets, net
Other noncurrent assets
Total Assets
Liabilities and Equity
Current Liabilities:
Accounts payable
Nonrelated Party
Related Party
Total accounts payable
Short-term borrowings
Current portion of long-term debt
Nonrelated Party
Related Party
Total current portion of long-term debt
Operating lease liabilities
Other current liabilities
Total current liabilities
Long-term debt
Nonrelated Party
Related Party
Total long-term debt
Deferred income tax liabilities
Noncurrent operating lease liabilities
Other noncurrent liabilities
Total Liabilities
Equity
Common stock, par value of $0.01 per share, 680,250,615 shares authorized, 566,875,513 issued and 549,779,621 outstanding as of June 30, 2026 566,875,513 issued and 553,082,525 outstanding as of December 31, 2025
Additional paid-in capital
Retained earnings
Net parent investment
Treasury stock, 17,095,892 shares as of June 30, 2026 and 13,792,988 shares as of December 31, 2025
Accumulated other comprehensive loss
Total equity attributable to the Company
Noncontrolling interests
Total Equity
Total Liabilities and Equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support